CATALYST PHARMACEUTICALS, INC. (CPRX) has 218 open-market insider trades by 19 insiders since 2007. The most active filer is Patrick J. McEnany, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Patrick J. McEnany | Dir | — | 44 | $81.2M | 2025-12-29 |
| Gary Ingenito | — | — | 15 | $26.8M | 2025-05-14 |
| Alicia Grande | CFOVPTreasurer | — | 15 | $18.6M | 2023-12-27 |
| Steve Miller | — | — | 12 | $16.1M | 2025-12-29 |
| Brian Elsbernd | — | — | 7 | $7.4M | 2025-12-29 |
| Jeffrey del Carmen | CCO | — | 6 | $6.8M | 2025-12-29 |
| Pharmaceutical Inc Biomarin | 10% | — | 1 | $3.8M | 2012-12-08 |
| David S. Tierney | Dir | — | 10 | $3.5M | 2025-12-29 |
| Philip H. Coelho | Dir | — | 27 | $3.3M | 2023-05-04 |
| Preethi Sundaram | CSO | — | 3 | $2.6M | 2025-12-29 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Molly Harper | Director | Sell | $1.2M | 2025-12-12 |
| Jeffrey del Carmen | CCO | Sell | $512K | 2025-11-26 |
| Brian Elsbernd | Chief Compliance/Legal Officer | Sell | $908K | 2025-11-12 |
| Brian Elsbernd | — | Sell | $609K | 2025-09-08 |
| Brian Elsbernd | — | Sell | $1.4M | 2025-09-03 |
| David S. Tierney | Director | Sell | $525K | 2025-08-27 |
Companies that share insiders with CPRX, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Steve Miller | — | Sell | $2.3M | 2025-08-26 |
| Richard J. Daly | CEO & President | Sell | $947K | 2025-08-26 |
| Preethi Sundaram | CSO | Sell | $165K | 2025-06-10 |
| Patrick J. McEnany | Director | Sell | $10.4M | 2025-06-06 |
| Richard J. Daly | President | Sell | $1.7M | 2025-05-30 |
| Gary Ingenito | — | Sell | $5.8M | 2025-05-13 |
| Gary Ingenito | — | Sell | $9.8M | 2025-03-05 |
| Brian Elsbernd | — | Sell | $2.9M | 2025-03-03 |
| Jeffrey del Carmen | CCO | Sell | $1.4M | 2025-03-03 |